China’s National Crop Variety Registration Committee (CNCVRC) has published its third list of genetically modified (GM) maize and soybean varieties approved for preliminary cultivation. The list, released on April 8, 2025, includes performance data, yield results, and regional suitability, and is currently open for public comment until May 9.
The move, which is a step toward advancing agricultural biotechnology, marks continued progress in China’s cautious but steady rollout of GM crops. While the Ministry of Agriculture and Rural Affairs (MARA) has previously approved biotech events for key crops such as maize and soybeans, actual commercialization requires approval of specific GM varieties through CNCVRC’s process.
This latest list builds on previous milestones: the first GM maize and soybean registration list was published in October 2023 and finalized in December that year, followed by a second list opened for comment in March 2024 and finalized in October 2024. With the addition of the April 2025 list, China has now approved a total of 64 GM maize varieties and 17 GM soybean varieties for cultivation.
Unlike some other regulatory systems, China’s approach mandates a dual approval process—first at the event level and subsequently for variety registration—ensuring robust oversight before commercialization. The latest approvals are part of China’s broader strategy to enhance crop yields, reduce pesticide use, and increase self-sufficiency in food production.
The move is being closely watched by global stakeholders in biotechnology and agriculture, particularly as China is one of the world’s largest importers of soybeans and maize. The increased acceptance of GM varieties is expected to have long-term implications for domestic farming, international trade, and food security.
The public consultation period offers an opportunity for researchers, industry representatives, and the general public to submit feedback before final decisions are made.
